Cardinal Health (CAH) Stock Price & Analysis

CAH$280.56+2.42 +0.87%
Medical - DistributionLarge Cap
Compare
Market cap$64.85BEnterprise value$67.53BRevenue (TTM)$257.75BMarket positionTop 25%

Score

47
Neutral
Value
40
Quality
43
Growth
58

AI Analysis

Snapshot

Cardinal Health is a mixed profile at 47/100 — Value 40, Growth 58, Quality 43. Under the hood: P/E 35.6, rich vs its own history, plus revenue compounding ~8% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

40
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

58
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

43
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Cardinal Health, Inc. (CAH) last printed $280.56. Equity value is $64.85B. Trailing earnings multiple 35.74. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2017201820192020202120222023202420252026
$129.98B$136.81B$145.53B$152.92B$162.47B$181.33B$204.98B$226.83B$222.58B$254.25B

About

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Cardinal Health (CAH) Stock Price & Analysis

CAH price $280.56 +2.42 +0.87%

Ticker
CAH
Price
$280.56
Change
+2.42 +0.87%
Market cap
$64.85B
P/E
35.74
Forward P/E
21.42
Dividend yield
0.74%
Beta
0.52
Sector
Healthcare
Industry
Medical - Distribution
Stocklytics score
47
Value
40
Quality
43
Growth
58

Stocklytics score rationale: value 40, quality 43, growth 58.

AI Score 45. Cardinal Health, Inc. has a high price-to-earnings ratio of 34.45, indicating potential overvaluation, while its net profit margin is low at 0.67%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener